pharmaceuticals Review Genomic Markers for Essential Tremor Félix Javier Jiménez-Jiménez 1,* , Hortensia Alonso-Navarro 1, Elena García-Martín 2, Ignacio Álvarez 3, Pau Pastor 3 and José A. G. Agúndez 2 1 Section of Neurology, Hospital Universitario del Sureste, E28500 Arganda del Rey, Spain;
[email protected] 2 ARADyAL Instituto de Salud Carlos III, University Institute of Molecular Pathology Biomarkers, University of Extremadura, E10071 Caceres, Spain;
[email protected] (E.G.-M.);
[email protected] (J.A.G.A.) 3 Movement Disorders Unit, Department of Neurology, University Hospital Mútua de Terrassa, Fundació Docencia i Recerça Mútua de Terrassa, E08221 Terrassa, Spain;
[email protected] (I.Á.);
[email protected] (P.P.) * Correspondence:
[email protected]; Tel.: +34-636-96-83-95; Fax: +34-913-28-07-04 Abstract: There are many reports suggesting an important role of genetic factors in the etiopatho- genesis of essential tremor (ET), encouraging continuing the research for possible genetic markers. Linkage studies in families with ET have identified 4 genes/loci for familial ET, although the re- sponsible gene(s) have not been identified. Genome-wide association studies (GWAS) described several variants in LINGO1, SLC1A2, STK32B, PPARGC1A, and CTNNA3, related with ET, but none of them have been confirmed in replication studies. In addition, the case-control association studies performed for candidate variants have not convincingly linked any gene with the risk for ET. Exome studies described the association of several genes with familial ET (FUS, HTRA2, TENM4, SORT1, SCN11A, NOTCH2NLC, NOS3, KCNS2, HAPLN4, USP46, CACNA1G, SLIT3, CCDC183, MMP10, and GPR151), but they were found only in singular families and, again, not found in other families or other populations, suggesting that some can be private polymorphisms.